C12N 2770/32662
By genetic engineering
Official title: by genetic engineering
C12N2770/32662 (By genetic engineering) appears on 16 US grants and 15 published applications in this corpus.
Search patents in C12N- Granted patents
- 16
- Published applications
- 15
- Assignees
- 6
- Inventors
- 32
- Latest grant
- 30 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for predicting tumor response to immunotherapy30 Aug 2022US 11,428,691 B2Duke University
- Attenuated viruses useful for vaccines2 Nov 2021US 11,162,080 B2The Research Foundation for The State University of New York
- Methods of making modified viral genomes17 Jul 2018US 10,023,845 B2The Research Foundation for The State University of New York
- Attenuated viruses useful for vaccines25 Oct 2016US 9,476,032 B2The Research Foundation for The State University of New York
- Inactivated poliovaccine2 Aug 2016US 9,402,892 B2The Secretary of State for Health
- Rna vectors with hairpin-like inserts17 Sep 2026US 2026/0275366 A1
- Attenuated viruses useful for vaccines11 Jul 2024US 2024/0228981 A1The Research Foundation for The State University of New York
- Attenuated viruses useful for vaccines22 Sep 2022US 2022/0298492 A1The Research Foundation for The State University of New York
- Methods For Predicting Tumor Response To Immunotherapy4 Mar 2021US 2021/0063398 A1Duke University
- Attenuated viruses useful for vaccines10 Jan 2019US 2019/0010469 A1The Research Foundation for The State University of New York
Most cited
By later US patents
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Recombinant plant viral nucleic acids105US 5,589,367 ABiosource Technologies, Inc. · 1996
- Recombinant plant viral nucleic acids86US 5,866,785 ABiosource Technologies, Inc. · 1999
- Recombinant plant viral nucleic acids73US 5,889,190 ABiosource Technologies, Inc. · 1999
- Cytoplasmic inhibition of gene expression by viral RNA42US 6,479,291 B2Large Scale Biology Corporation · 2002